A. Leigh Corbett
Staff Reporter
Phone: 949-833-8373 Extension: 254
Recent Stories
A Love for Plastic Surgery
Niccole Aims to Make People Feel Fabulous
Dr. Michael Niccole is happiest when he does a surgery to improve a person’s looks.
Moms OC’s CEO To CalOptima Board
Pimentel Runs OC’s No. 59 Nonprofit
Chief Executive Pamela Pimentel at Moms Orange County was named to the advisory board of CalOptima, a public health insurance program for low-income individuals.
UCI Study Shows Promise in MS Battle
Stem Cells Used For Nanotech Treatment
UCI researchers said they successfully used a nanotechnology treatment derived from bone marrow stem cells to reverse multiple sclerosis symptoms in mice.
Evolus Says Europe Seeking More Data
Decision Delayed For Europe’s Version of Jeuveau
Newport Beach-based Evolus Inc. (Nasdaq: EOLS) said the European Commission is taking longer than expected to reach a decision on marketing approval for Nuceiva, its European version of the competitor to Allergan’s Botox.
Midday Stock Roundup
The S&P 500 is up 0.4% to 2,890.27 in midday trading.
Applied Innovation Showcases Advances, Entrepreneurs
Event Follows New Beall Family Donation
Elliot Botvinick, Ph.D., a University of California-Irvine professor who is involved in two startups, took home the prize of Entrepreneurial Leader of the Year at UCI’s Applied Innovation’s second annual award ceremony on May 29.
Cryoport’s Hot on Acquisitions
$20.5M Cash Buy of Cryogene
Cryoport Inc. (Nasdaq: CYRX), a provider of cold-chain logistics services for the biopharmaceutical industry, is a hot stock.
Avid Aims for Rebound After CEO Departure
New Analyst Sets $5 Price Target
Tustin-based Avid Bioservices Inc. (Nasdaq: CDMO), a pharmaceutical contract manufacturer that’s seen its share of change the past year, might be returning to the light as its stock gains traction, and the attention of a new analyst.
Midday Stock Report
The S&P 500 rose 0.2% to 2,833.79 in midday trading.
AR Glasses Pass Trial
Eyedaptic Tied to UCI Herbert Institute
Ophthalmology software startup Eyedaptic Inc. in Laguna Beach said it has completed a successful clinical trial for its augmented reality glasses, which are designed to improve quality of life for those suffering from macular degeneration—nearly 150 million people worldwide.
